2/1/19
by News Department on 02/01/19RECALL...
A New Jersey-based pharmaceutical company has expanded a November 2018 recall of liquid infant ibuprofen that might be more concentrated than advertised.
Tris Pharma says there is a “remote possibility” that infants more susceptible to medication with a higher potency of ibuprofen might suffer permanent renal injury.
The company says that to date, no serious adverse events have been reported in relation to this recall.
Consumers, who may be concerned, should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Consumers with questions regarding the recall can contact Tris Customer Service at (732) 940-0358.
